Matches in SemOpenAlex for { <https://semopenalex.org/work/W2593955110> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2593955110 endingPage "197" @default.
- W2593955110 startingPage "192" @default.
- W2593955110 abstract "To evaluate safety and efficacy of autologous peripheral blood hematopoietic stem cell transplantation (auto-PBHSCT) with IBu precondition regimen consisting of high-dose idarubicin (IDA) and busulphan (Bu) for treatment of patients with low and intermediate risk acute myeloid leuekmia (AML).A total of 11 patients with AML (5 low and 6 intermediate risk patients) treated with auto-PBHSCT with IBu precondition regimen (IDA 20 mg/m2, continuous i.v. from d-13 to d-11, Bu 0.8 mg/kg/q6h i.v. for 2h, from d-5 to d-2) from March 2011 to July 2014 were analyzed retrospectively. Adverse effects and transplantation-related mortality (TRM) were evaluated. Kaplan-Meier analysis was performed to calculate the overall survival (OS), disease-free survival (DFS) and cumulative relapse rate (RR). Cox regression was performed for univariate analysis for DFS.Among the 11 patients, 10 patients obtained hematopoietic reconstitution, 1 patient died during transplantation, thus the TRM was 9.1%. The adverse effects were well tolerated. With median follow-up of 31.6 (8.7-52.5) months, 7 patients (63.3%) were alive, including 6 patients (54.5%) in continuous complete remission (CR). Median OS and DFS were not reached. The 3-year OS, DFS and RR were (57.7±16.3)%, (52.5±17.6)% and 47.5%, respectively. Univartiate analysis indicated that the age, sex, interval between diagnosis and transplantation, white blood cell count at diagnosis, risk-grouping (low or intermediate risk), disease status before transplantation (CR1 or CR2), and count of mononuclear cells for infusion all can not influence DFS(P>0.05, respectively).The treatment of auto-PBHSCT with IBu precondition regimen for low to intermediate risk AML patients is safe and effective." @default.
- W2593955110 created "2017-03-16" @default.
- W2593955110 creator A5009038877 @default.
- W2593955110 creator A5016406818 @default.
- W2593955110 creator A5022098811 @default.
- W2593955110 creator A5024202290 @default.
- W2593955110 creator A5027657298 @default.
- W2593955110 creator A5067484634 @default.
- W2593955110 creator A5085552878 @default.
- W2593955110 date "2017-02-01" @default.
- W2593955110 modified "2023-10-16" @default.
- W2593955110 title "[Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation with IBu Precondition Regimen in Treatment for 11 Patients with Low to Intermediate Risk Acute Myeloid Leukemia]." @default.
- W2593955110 doi "https://doi.org/10.7534/j.issn.1009-2137.2017.01.034" @default.
- W2593955110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28245400" @default.
- W2593955110 hasPublicationYear "2017" @default.
- W2593955110 type Work @default.
- W2593955110 sameAs 2593955110 @default.
- W2593955110 citedByCount "0" @default.
- W2593955110 crossrefType "journal-article" @default.
- W2593955110 hasAuthorship W2593955110A5009038877 @default.
- W2593955110 hasAuthorship W2593955110A5016406818 @default.
- W2593955110 hasAuthorship W2593955110A5022098811 @default.
- W2593955110 hasAuthorship W2593955110A5024202290 @default.
- W2593955110 hasAuthorship W2593955110A5027657298 @default.
- W2593955110 hasAuthorship W2593955110A5067484634 @default.
- W2593955110 hasAuthorship W2593955110A5085552878 @default.
- W2593955110 hasConcept C126322002 @default.
- W2593955110 hasConcept C141071460 @default.
- W2593955110 hasConcept C144301174 @default.
- W2593955110 hasConcept C197934379 @default.
- W2593955110 hasConcept C2777408962 @default.
- W2593955110 hasConcept C2778041864 @default.
- W2593955110 hasConcept C2778729363 @default.
- W2593955110 hasConcept C2779117419 @default.
- W2593955110 hasConcept C2781413609 @default.
- W2593955110 hasConcept C2911091166 @default.
- W2593955110 hasConcept C38180746 @default.
- W2593955110 hasConcept C71924100 @default.
- W2593955110 hasConcept C88879693 @default.
- W2593955110 hasConcept C90924648 @default.
- W2593955110 hasConceptScore W2593955110C126322002 @default.
- W2593955110 hasConceptScore W2593955110C141071460 @default.
- W2593955110 hasConceptScore W2593955110C144301174 @default.
- W2593955110 hasConceptScore W2593955110C197934379 @default.
- W2593955110 hasConceptScore W2593955110C2777408962 @default.
- W2593955110 hasConceptScore W2593955110C2778041864 @default.
- W2593955110 hasConceptScore W2593955110C2778729363 @default.
- W2593955110 hasConceptScore W2593955110C2779117419 @default.
- W2593955110 hasConceptScore W2593955110C2781413609 @default.
- W2593955110 hasConceptScore W2593955110C2911091166 @default.
- W2593955110 hasConceptScore W2593955110C38180746 @default.
- W2593955110 hasConceptScore W2593955110C71924100 @default.
- W2593955110 hasConceptScore W2593955110C88879693 @default.
- W2593955110 hasConceptScore W2593955110C90924648 @default.
- W2593955110 hasIssue "1" @default.
- W2593955110 hasLocation W25939551101 @default.
- W2593955110 hasOpenAccess W2593955110 @default.
- W2593955110 hasPrimaryLocation W25939551101 @default.
- W2593955110 hasRelatedWork W2004368639 @default.
- W2593955110 hasRelatedWork W2049271851 @default.
- W2593955110 hasRelatedWork W2117630751 @default.
- W2593955110 hasRelatedWork W2145829737 @default.
- W2593955110 hasRelatedWork W2355885759 @default.
- W2593955110 hasRelatedWork W2516907989 @default.
- W2593955110 hasRelatedWork W2530381899 @default.
- W2593955110 hasRelatedWork W2589790903 @default.
- W2593955110 hasRelatedWork W2948755618 @default.
- W2593955110 hasRelatedWork W3029970172 @default.
- W2593955110 hasVolume "25" @default.
- W2593955110 isParatext "false" @default.
- W2593955110 isRetracted "false" @default.
- W2593955110 magId "2593955110" @default.
- W2593955110 workType "article" @default.